DK174072B1 - Farmaceutisk formulering samt anvendelse heraf til fremstilling af et middel til behandling af kredsløbssygdomme. - Google Patents

Farmaceutisk formulering samt anvendelse heraf til fremstilling af et middel til behandling af kredsløbssygdomme. Download PDF

Info

Publication number
DK174072B1
DK174072B1 DK200100444A DKPA200100444A DK174072B1 DK 174072 B1 DK174072 B1 DK 174072B1 DK 200100444 A DK200100444 A DK 200100444A DK PA200100444 A DKPA200100444 A DK PA200100444A DK 174072 B1 DK174072 B1 DK 174072B1
Authority
DK
Denmark
Prior art keywords
formulation according
daily dose
cholesterol
root
formulation
Prior art date
Application number
DK200100444A
Other languages
Danish (da)
English (en)
Inventor
Hans Ole Svendsen
Original Assignee
M B Pharmos Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M B Pharmos Aps filed Critical M B Pharmos Aps
Priority to DK200100444A priority Critical patent/DK174072B1/da
Priority to DE60202446T priority patent/DE60202446T8/de
Priority to ES02704637T priority patent/ES2236487T3/es
Priority to AT02704637T priority patent/ATE285784T1/de
Priority to PCT/DK2002/000177 priority patent/WO2002074319A1/en
Priority to EP02704637A priority patent/EP1368046B1/en
Application granted granted Critical
Publication of DK174072B1 publication Critical patent/DK174072B1/da
Publication of DK200100444A publication Critical patent/DK200100444A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A61K36/515—Gentiana
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK200100444A 2001-03-15 2001-03-15 Farmaceutisk formulering samt anvendelse heraf til fremstilling af et middel til behandling af kredsløbssygdomme. DK174072B1 (da)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DK200100444A DK174072B1 (da) 2001-03-15 2001-03-15 Farmaceutisk formulering samt anvendelse heraf til fremstilling af et middel til behandling af kredsløbssygdomme.
DE60202446T DE60202446T8 (de) 2001-03-15 2002-03-15 Pharmazeutische formulierung und ihre verwendung für die herstellung eines medikaments zur behandlung von herz-kreislauf-erkrankungen
ES02704637T ES2236487T3 (es) 2001-03-15 2002-03-15 Formulacion farmaceutica y su uso para preparar un medicamento para el tratamiento de enfermedades cardiovasculares.
AT02704637T ATE285784T1 (de) 2001-03-15 2002-03-15 Pharmazeutische formulierung und ihre verwendung für die herstellung eines medikaments zur behandlung von herz-kreislauf-erkrankungen
PCT/DK2002/000177 WO2002074319A1 (en) 2001-03-15 2002-03-15 Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases
EP02704637A EP1368046B1 (en) 2001-03-15 2002-03-15 Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK200100444 2001-03-15
DK200100444A DK174072B1 (da) 2001-03-15 2001-03-15 Farmaceutisk formulering samt anvendelse heraf til fremstilling af et middel til behandling af kredsløbssygdomme.

Publications (2)

Publication Number Publication Date
DK174072B1 true DK174072B1 (da) 2002-05-21
DK200100444A DK200100444A (da) 2002-05-21

Family

ID=8160371

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200100444A DK174072B1 (da) 2001-03-15 2001-03-15 Farmaceutisk formulering samt anvendelse heraf til fremstilling af et middel til behandling af kredsløbssygdomme.

Country Status (6)

Country Link
EP (1) EP1368046B1 (es)
AT (1) ATE285784T1 (es)
DE (1) DE60202446T8 (es)
DK (1) DK174072B1 (es)
ES (1) ES2236487T3 (es)
WO (1) WO2002074319A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339101B (es) 2011-03-11 2016-05-11 Jose Arturo Castañeda Miranda Polifarmaco herbario para la prevencion y el tratamiento de la ateroesclerosis.
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US20160106722A1 (en) 2014-10-21 2016-04-21 Life Plus, LLC Human therapeutic agents
CN107496849A (zh) * 2017-10-11 2017-12-22 湖南中医药大学 一种治疗冠心病的药物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0739350B2 (ja) * 1990-08-03 1995-05-01 ゼリア新薬工業株式会社 生薬配合チュアブル錠
US6440464B1 (en) * 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
CN1209281A (zh) * 1998-07-30 1999-03-03 李树春 月苋草花茶

Also Published As

Publication number Publication date
DE60202446D1 (de) 2005-02-03
DK200100444A (da) 2002-05-21
EP1368046A1 (en) 2003-12-10
ATE285784T1 (de) 2005-01-15
EP1368046B1 (en) 2004-12-29
DE60202446T8 (de) 2006-08-24
WO2002074319A1 (en) 2002-09-26
DE60202446T2 (de) 2006-01-12
ES2236487T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
Chapman et al. Cilostazol: a review of its use in intermittent claudication
US20010034338A1 (en) Composition and method for reducing serum cholesterol levels
EP3590356A1 (en) Composition for controlling and reducing blood cholesterol levels
KR100399671B1 (ko) 고혈압증또는이에기인하는의학적증상의예방또는개선제
AU2002227771B2 (en) Regulation of lipids and/or bone density and compositions therefor
WO2000064438A1 (en) Cardiovascular and bone treatment using isoflavones
EP1748774B1 (en) Compositions comprising flavonoids and tocotrienols and uses thereof
AU2005247160A1 (en) Functional foods comprising flavonoids and tocotrienols and methods thereof
JP2012051940A (ja) ビワ葉抽出物を含有する飲食品及び医薬品
AU2002227771A1 (en) Regulation of lipids and/or bone density and compositions therefor
DK174072B1 (da) Farmaceutisk formulering samt anvendelse heraf til fremstilling af et middel til behandling af kredsløbssygdomme.
JP2008222656A (ja) 肥満改善および予防用組成物ならびに健康食品
JPS6299323A (ja) 高脂血症剤
AU2006300629A1 (en) Agent for inhibiting Visceral fat accumulation
Strisower et al. Effect of ileal bypass on serum lipoproteins in essential hypercholesterolemia
JP2009096757A (ja) 脂肪代謝抑制剤
McKoy et al. Investigation of the effects of a sapogenin-rich preparation from a Jamaican yam (Dioscorea sp.) on blood cholesterol levels in rats
JP2004155780A (ja) 生活習慣病改善剤組成物
WO2013117733A1 (en) Kudzu and plant sterols and their effect on cardiovascular diseases
KR20070108291A (ko) 알레르기 증상의 예방 또는 개선 작용을 갖는 음식물 및당해 음식물의 제조방법
CN114177185B (zh) 一种用于降低胆固醇与预防心血管疾病的药物组合物
AU761047B2 (en) Cardiovascular and bone treatment using isoflavones
Marais et al. Atorvastatin is a powerful and safe agent for lowering plasma cholesterol concentration in heterozygous familial hypercholesterolemia
ITRM20060203A1 (it) Composizione a base di preparazioni estrattive di piante officinali e edule per il trattamento delle dislipidemie
Kostner et al. Lipid-apheresis reduces plasma cholesterol but not apolipoproteins AI and B

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Ref document number: DK